A novel hGHRH analog and its comparative activity.

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Growth hormone-releasing hormone (GHRH) is crucial for growth but has a short half-life and is expensive to synthesize.
• There is a need for GHRH analogs with enhanced activity and prolonged half-life for therapeutic and agricultural applications.

Purpose of the Study:

• To create and characterize a novel fusion protein analog of GHRH with improved properties.
• To evaluate the growth hormone-releasing activity and specificity of the developed GHRH analog.

Main Methods:

• A fusion protein was constructed by recombining L-asparaginase gene with asp-pro-hGHRH(1-44) using PCR.
• Purification involved multiple chromatography steps, and molecular weight was confirmed by EIS-MS.
• In vitro assays assessed the peptide's effect on GH release from rat and human pituitary cells.

Main Results:

• The GHRH analog increased GH release from rat pituitary cells in a dose-dependent manner.
• The analog showed significant GH-releasing activity in human fetal pituitary cells.
• Structure-activity relationship studies indicated superior activity of the Pro-hGHRH(1-44) analog compared to Pro-Pro-hGHRH(1-44).

Conclusions:

• The novel GHRH fusion protein analog exhibits potent and specific growth hormone-releasing activity.
• This analog demonstrates potential for overcoming the limitations of native GHRH, suggesting therapeutic promise.
• The study highlights the analog's function-selectivity and species specificity in hormone release.